The workplace can have a significant impact on mental health, with 15% of working-age adults estimated to have a mental disorder in 2019. Traditional treatments are sometimes inadequate, leading to interest in expanding access to psychedelic-assisted therapy. Ketamine and psilocybin, two types of psychedelics, show promise in mental health treatment. Employers play a crucial role in supporting employees’ mental health, as workplace stress can lead to physical health issues. Employers can offer psychedelic treatments as a workplace benefit to help address mental health challenges and reduce the economic costs associated with untreated mental health issues.
Source link
4 Things Employers Should Know About Psychedelic Medicines
